Cleared Traditional

K992007 - PHARMASEED, MODEL BT-103-1

K992007 is an FDA 510(k) clearance for PHARMASEED, manufactured by Syncor Pharmaceuticals, Inc.. The device is a Class 2 Radiology device with product code KXK cleared through the Traditional 510(k) pathway after a 213-day FDA review.

K992007 · Syncor Pharmaceuticals, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2000
Decision
213d
Days
Class 2
Risk

K992007 is an FDA 510(k) clearance for the PHARMASEED, MODEL BT-103-1. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Syncor Pharmaceuticals, Inc. (Golden, US). The FDA issued a Cleared decision on January 14, 2000 after a review of 213 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Syncor Pharmaceuticals, Inc. devices

FDA 510(k) Submission Details - K992007

510(k) Number K992007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 1999
Decision Date January 14, 2000
Days to Decision 213 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d slower than avg
Panel avg: 107d · This submission: 213d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 47
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K992007.
LOOK COLLAGEN SPACERS, MODEL 1514B
K001765 · Surgical Specialties Corp · Sep 2000
125-IMPLANT SEEDS, MODEL STM1250
K991881 · Sourcetech Medical, LLC · Mar 2000
10 CURIE IRDIUM 192, CSN00100-192
K991571 · Alpha-Omega Services, Inc. · Feb 2000
PHARMASEED, MODEL BT-125-1
K992008 · Syncor Pharmaceuticals, Inc. · Dec 1999
WORLDWIDE MEDICAL TECHNOLOGIES SEEDING SPACERS
K991344 · Worldwide Medical Technologies, LLC · Nov 1999
125 IMPLANT SEEDS, MODEL STM1251
K991280 · Sourcetech Medical, LLC · Oct 1999